SLC22A1 and neoplasm: Immunoblotting revealed that the downregulation of Slc22A1 mRNA expression in tumor tissue in comparison to TST as measured in the qPCR (Figure 4A, 4B) correlates with the corresponding protein levels in liver tumors and TST in Oct3−/− and WT mice (Figure 4C).